| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.601 | 14.808 | 18.553 | 2.579 | 2.529 | 2.834 | 2.580 | 2.640 | 2.426 | 2.412 |
| Total Income - EUR | -4.973 | 16.470 | 20.742 | 430 | 11.354 | 2.834 | 2.580 | 2.640 | 2.426 | 2.412 |
| Total Expenses - EUR | 21.966 | 11.701 | 19.503 | 3.980 | 15.244 | 2.973 | 21.741 | 10.412 | 8.173 | 4.419 |
| Gross Profit/Loss - EUR | -26.939 | 4.770 | 1.239 | -3.550 | -3.891 | -139 | -19.161 | -7.772 | -5.747 | -2.007 |
| Net Profit/Loss - EUR | -27.557 | 4.621 | 1.053 | -3.615 | -4.231 | -217 | -19.226 | -7.851 | -5.747 | -2.007 |
| Employees | 4 | 5 | 4 | 3 | 3 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Bioing Sa
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.911 | 6.591 | 6.454 | 6.335 | 32.658 | 32.038 | 12.947 | 5.357 | 904 | 899 |
| Current Assets | 11.611 | 13.405 | 13.736 | 8.967 | 7.389 | 7.011 | 6.410 | 5.144 | 5.395 | 5.748 |
| Inventories | 0 | 84 | 2.096 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.849 | 6.779 | 6.664 | 6.542 | 5.916 | 5.598 | 5.664 | 4.735 | 4.974 | 5.290 |
| Cash | 4.762 | 6.542 | 4.975 | 2.425 | 1.473 | 1.413 | 746 | 409 | 421 | 458 |
| Shareholders Funds | 10.358 | 14.874 | 15.676 | 11.774 | 7.314 | 6.959 | -12.209 | -20.098 | -26.091 | -27.952 |
| Social Capital | 31.946 | 31.620 | 31.085 | 30.515 | 29.924 | 29.356 | 28.705 | 28.794 | 28.707 | 28.547 |
| Debts | 6.486 | 5.122 | 4.513 | 3.529 | 32.732 | 32.091 | 31.566 | 30.599 | 32.390 | 34.599 |
| Income in Advance | 1.678 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Bioing Sa